Previous studies showed that IFN directly inhibits CML cells [13], [14], although this mechanism cannot explain persistence of cytogenetic or molecular remission many years after stopping IFN. Here, IFNA1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.